MiMedx Group, Inc. (MDXG)
4.71
-0.06
(-1.26%)
USD |
NASDAQ |
Sep 24, 16:00
4.705
0.00 (0.00%)
After-Hours: 19:59
MiMedx Group Gross Profit (Annual) : 344.21M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 344.21M |
| December 31, 2024 | 287.17M |
| December 31, 2023 | 264.98M |
| December 31, 2022 | 217.30M |
| December 31, 2021 | 211.94M |
| December 31, 2020 | 204.07M |
| December 31, 2019 | 247.64M |
| December 31, 2018 | 315.81M |
| December 31, 2017 | 280.16M |
| December 31, 2016 | 210.48M |
| Date | Value |
|---|---|
| December 31, 2015 | 166.16M |
| December 31, 2014 | 104.63M |
| December 31, 2013 | 48.80M |
| December 31, 2012 | 21.56M |
| December 31, 2011 | 2.823M |
| December 31, 2010 | -2.043M |
| March 31, 2009 | -1.092M |
| March 31, 2008 | -0.5003M |
| March 31, 2007 | -0.0157M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Anika Therapeutics, Inc. | 63.81M |
| Perspective Therapeutics, Inc. | -2.367M |
| ABVC BioPharma, Inc. | -0.5048M |
| Enovis Corp. | 1.166B |
| Edwards Lifesciences Corp. | 4.728B |